- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Plasma Volume in Canada
Total 295 results
-
GlaxoSmithKlineMerck Sharp & Dohme LLCCompletedMultiple MyelomaSpain, Germany, United States, Canada
-
University Health Network, TorontoCelgene Corporation; Otsuka Pharmaceutical Development & Commercialization,... and other collaboratorsCompleted
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Breast Cancer | Chronic Myeloproliferative Disorders | Anemia | Small Intestine Cancer | Lung Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Drug/Agent Toxicity by Tissue/OrganUnited States, Canada
-
PfizerRecruitingMultiple MyelomaCanada, France, Japan, Australia, United States
-
CARsgen Therapeutics Co., Ltd.Active, not recruitingMultiple MyelomaUnited States, Canada
-
SanofiRecruitingPlasma Cell MyelomaGermany, United States, Argentina, China, France, Hong Kong, Italy, Japan, Puerto Rico, Spain, Switzerland, United Arab Emirates, United Kingdom, Austria, Belgium, Netherlands, Taiwan
-
CelgeneActive, not recruitingMultiple MyelomaSpain, Canada, United States
-
PETHEMA FoundationMillennium Pharmaceuticals, Inc.; CelgeneCompleted
-
Genentech, Inc.CompletedMultiple MyelomaUnited States, Canada
-
Otsuka Pharmaceutical Development & Commercialization...CompletedMultiple MyelomaUnited States, Canada
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...Recruiting
-
NovartisCompletedMultiple MyelomaCanada, United States, Australia, Taiwan, Ireland
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)TerminatedPrimary Systemic Amyloidosis | Light Chain Deposition DiseaseUnited States, Canada
-
German CLL Study GroupCompletedChronic Lymphocytic LeukemiaCanada, Germany
-
Bristol-Myers SquibbRecruitingMultiple MyelomaNorway, United States, Spain, United Kingdom, Canada
-
Millennium Pharmaceuticals, Inc.CompletedMultiple Myeloma | Advanced Solid TumorsUnited States, Canada
-
AmgenCompletedRelapsed Multiple MyelomaUnited States, Canada
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Italy, Canada, France, Germany, Netherlands, Spain
-
CelgeneActive, not recruitingMultiple MyelomaFrance, United States, Canada, Spain, Italy
-
AbbVieGenentech, Inc.; Celgene CorporationWithdrawnMultiple MyelomaUnited States, Australia, Canada, Spain
-
Pharmacyclics LLC.CompletedMultiple MyelomaUnited States, Canada
-
SanofiActive, not recruitingPlasma Cell MyelomaItaly, Korea, Republic of, Norway, Canada, Spain, Germany, Greece, Lithuania, Sweden, Israel, Hungary, France, Japan, Australia, China, Denmark, Czechia, Turkey, United States, Brazil, Ireland, New Zealand, Poland, United Kingdom
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnLymphomaUnited States, Australia, United Kingdom, Canada, France
-
Cleave Biosciences, Inc.TerminatedLymphoid Hematological Malignancies | Relapsed and Refractory Multiple MyelomaCanada, United States
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited Kingdom, Spain, Canada, United States, Czechia
-
ModernaTX, Inc.WithdrawnRelapsed or Refractory Multiple MyelomaUnited States, Canada
-
Genentech, Inc.RecruitingMultiple MyelomaUnited States, Canada, Spain, Australia
-
European Society for Blood and Marrow TransplantationCompletedMultiple MyelomaAustria, Denmark, Germany, Finland, Canada, Sweden, Norway, France, Italy, United Kingdom, Turkey
-
Cedars-Sinai Medical CenterEnrolling by invitationAmyloidosis, Immunoglobulin Light-chainUnited States, Canada
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaCanada, United States, Germany, Netherlands, Spain
-
Karyopharm Therapeutics IncBristol-Myers SquibbActive, not recruitingMultiple MyelomaUnited States, Canada
-
TakedaTerminatedRelapsed and/or Refractory Multiple Myeloma (RRMM)United States, Canada
-
Gilead SciencesCompletedMultiple MyelomaUnited States, Czechia, Canada
-
PETHEMA FoundationJanssen, LP; Adknoma Health ResearchRecruitingMultiple Myeloma | Non-eligible for Autologous Stem Cell Transplantation (ASCT)Spain
-
Novartis PharmaceuticalsCompletedMultiple MyelomaGermany, Italy, Spain, Canada, United States, Australia
-
Celgene CorporationCompletedMultiple MyelomaUnited States, Canada
-
CelgeneCompletedMultiple Myeloma | Renal ImpairmentUnited States, Canada
-
CelgeneCompleted
-
K36 Therapeutics, Inc.RecruitingMultiple Myeloma | Myeloma | Myeloma MultipleUnited States, France, Spain, Canada
-
PfizerAvailableMultiple MyelomaUnited States, Canada
-
PETHEMA FoundationCabyc, S.L.Active, not recruiting
-
Janssen Research & Development, LLCCompleted
-
PETHEMA FoundationGlaxoSmithKlineRecruitingRELAPSED AND/OR REFRACTORY MULTIPLE MYELOMASpain
-
PETHEMA FoundationActive, not recruiting
-
AstraZenecaRecruitingMultiple MyelomaUnited States, Spain, Australia, Canada, France, China, Japan, Germany
-
Human Genome Sciences Inc.CompletedMultiple MyelomaUnited States, Canada, Australia, India
-
Poniard PharmaceuticalsTerminatedMultiple MyelomaUnited States, Canada
-
PfizerCompletedMultiple MyelomaCanada, United States
-
CelgeneCompletedMultiple MyelomaUnited States, Canada, Germany, Spain, Denmark, Netherlands, Finland, Italy
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedLymphomaUnited States, Canada, United Kingdom, Sweden